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Abstract
Obesity has deleterious effects on cognitive function in the elderly adults. In mice, aging exacerbates obesity-induced oxidative stress, 
microvascular dysfunction, blood–brain barrier (BBB) disruption, and neuroinflammation, which compromise cognitive health. However, the 
specific mechanisms through which aging and obesity interact to remain elusive. Previously, we have shown that Nrf2 signaling plays a critical 
role in microvascular resilience to obesity and that aging is associated with progressive Nrf2 dysfunction, promoting microvascular impairment. 
To test the hypothesis that Nrf2 deficiency exacerbates cerebromicrovascular dysfunction induced by obesity Nrf2+/+ and Nrf2-/-, mice were fed 
an adipogenic high-fat diet (HFD). Nrf2 deficiency significantly exacerbated HFD-induced oxidative stress and cellular senescence, impairment 
of neurovascular coupling responses, BBB disruption, and microglia activation, mimicking the aging phenotype. Obesity in Nrf2-/- mice elicited 
complex alterations in the amyloidogenic gene expression profile, including upregulation of amyloid precursor protein. Nrf2 deficiency 
and obesity additively reduced long-term potentiation in the CA1 area of the hippocampus. Collectively, Nrf2 dysfunction exacerbates the 
deleterious effects of obesity, compromising cerebromicrovascular and brain health by impairing neurovascular coupling mechanisms, BBB 
integrity and synaptic function and promoting neuroinflammation. These results support a possible role for age-related Nrf2 dysfunction in 
the pathogenesis of vascular cognitive impairment and Alzheimer’s disease.
Keywords: Vascular cognitive impairment, Vascular cognitive impairment, Long-term potentiation, Vascular contributions to cognitive impairment and dementia, 
Endothelial dysfunction
Currently, close to 70% of Americans aged 65  years and over 
are overweight and over 35% are obese and it is predicted that 
nearly half of the elderly population in the United States will be 
obese by 2030. Epidemiological and clinical studies, including the 
Framingham Offspring Study, demonstrate that a negative correla-
tion exists between adiposity and cognitive function and that the del-
eterious effects of obesity on higher cortical function are exacerbated 
in the elderly adults (1–4). Common mechanisms that contribute to 
the effects of aging and obesity are hypothesized to increase suscepti-
bility to both vascular cognitive impairment (VCI) and neurodegen-
eration, including Alzheimer’s disease.
There is an increasing appreciation that alterations at the level of 
the cerebral microcirculation play a key role in the pathogenesis of both 
VCI and Alzheimer’s disease (AD) in elderly patients (5,6). Preclinical 
studies provide direct mechanistic evidence that advanced age and obe-
sity have multifaceted synergistic effects compromising cerebromicro-
vascular health (7–10), which are causally linked to cognitive decline.
Normal functioning of the central nervous system requires a con-
tinuous, tightly-controlled supply of oxygen and nutrients as well as 
washout of harmful metabolites through uninterrupted cerebral blood 
flow (CBF) (5). During periods of intense neuronal activity, there is 
a requirement for rapid adaptive increases in CBF, which is ensured 
by a mechanism known as neurovascular coupling. Impairment of 
neurovascular coupling responses has been causally linked to cogni-
tive decline (11). Previous studies demonstrate that obesity results in 
neurovascular uncoupling, which is markedly exacerbated at old age 
(8). Although the available clinical and preclinical data suggest that 
advanced age and obesity have synergistic vascular effects (7–9), there 
are no studies addressing the specific age-related mechanisms through 
which aging exacerbates obesity-induced neurovascular uncoupling.
There is also increasing evidence to support an essential role 
for factors that compromise the integrity of the blood–brain bar-
rier (BBB) in the onset and progression of both VCI and Alzheimer’s 
disease (12), by triggering neuroinflammation, synaptic dysfunction, 
and neurodegeneration. Experimental and clinical studies suggest 
that obesity promotes BBB breakdown and activates inflammatory 
processes, which contribute to obesity-related impairment of cogni-
tive function (13,14). Importantly, aging was shown to exacerbate 
obesity-induced BBB disruption and neuroinflammation (7), yet, the 
underlying mechanisms remain obscure.
NF-E2-related factor 2 (Nrf2) is an evolutionarily highly con-
served pro-survival transcription factor that upregulates the expres-
sion of numerous genes involved in cellular resilience including 
enzymes that detoxify reactive oxygen species (ROS), as well as 
those with other antioxidant properties (15–19). In young organ-
isms, Nrf2-driven pathways attenuate vascular oxidative stress and 
limit the damage caused by the increased production of ROS induced 
by obesity (18,19). Previously, we have demonstrated that aging is 
associated with Nrf2 dysfunction in the vasculature, which was pro-
posed to increase sensitivity of aged organisms to oxidative stress-
induced vascular damage (20,21). Further, indirect evidence raises 
the possibility that impaired Nrf2 signaling and increased cerebral 
oxidative stress may contribute to obesity-induced declines in cogni-
tive performance in the aged brain (22).
The present study was designed to directly test the hypothesis 
that Nrf2 deficiency exacerbates obesity-induced neurovascular dys-
function, BBB disruption, neuroinflammation, and synaptic dysfunc-
tion in the hippocampus, mimicking the aging phenotype. To test 
our hypothesis, we assessed changes in whisker stimulation-induced 
functional hyperaemia in the somatosensory cortex, BBB function, 
microglia activation, hippocampal cytokine expression, and markers 
of oxidative stress in high-fat diet-fed obese Nrf2 deficient (Nrf2-/-) 
and wild type mice. To determine whether enhanced neuroinflamma-
tion triggers early processes involved in the development of VCI and/
or AD, we also studied long-term potentiation (LTP) and hippocam-
pal expression of genes involved in regulation of the cellular amyloid 
precursor protein (APP)-dependent signaling pathways, β-amyloid 
generation and the pathogenesis of tauopathy.
Methods
Experimental Animals, High-fat Diet Feeding
Male WT mice (Nrf2+/+) and Nrf2 KO mice on an Institute of 
Cancer Research (ICR) background (Nrf2-/-) were used as reported 
previously (16–18). In this study, only male mice were studied to 
exclude the possible confounding effects of the estrous cycle in 
females. The mice were housed in an environmentally-controlled 
vivarium with unlimited access to water and a controlled photo-
period (12-hour light; 12-hour dark). Body weight was recorded 
biweekly. All mice were maintained according to National Institutes 
of Health guidelines and all animal use protocols were approved by 
the Institutional Animal Care and Use Committees of the partici-
pating institutions. At 3 months of age, both wild-type control and 
Nrf2-/- mice were assigned to two groups and were fed a standard 
D12492 diet (SD; 10% kcal from fat) or D12450B diet modified 
to provide 60% of calories from fat (high-fat diet; HFD; Research 
Diets Inc., New Brunswick, NJ), as described previously (23). The 
animals continued on the specific diets (with water and food ad 
libitum) for 5 months. There was considerable variation in the ini-
tial body weight (41 ± 2 g and 36 ± 2 g for Nrf2+/+ and Nrf2-/- mice, 
respectively) and HFD-induced weight gain in the mice and the 
intent of the studies was to determine the influence of HFD and 
Nrf2 on cerebromicrovascular health, independent of body weight 
gain differences. Therefore, we selected a cohort of mice from the 
larger population with a similar HFD-induced gain in mean body 
weight (≥20%), which indicates that results in Figures 1–4 are inde-
pendent of body weight gain differences. An inherited retinal defect 
leading to rapid degeneration of photoreceptor cells is known to 
develop in ICR mice that are homozygous for a recessive mutation 
in the Pdebrd1 gene (24). As impaired vision confounds the effects of 
behavioral studies, we screened the animals for the presence of this 
mutation in their genome and excluded homozygous carriers (n = 3) 
from the behavioral studies.
Serum Biomarkers
Whole blood was collected at sacrifice and was centrifuged at 2,500 x g 
for 20 minutes at 4°C; serum was collected, aliquoted, and stored at 
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−80°C. Blood glucose was determined using an Ascensia Elite glu-
cose meter (Bayer, Mishawaka, IN). The serum biochemical profile 
was assessed by Vance Veterinary Laboratories (Oklahoma City, 
OK). Circulating levels of cytokines, chemokines, and other inflam-
matory markers relevant for aging research (7–9,23,25) were ana-
lyzed using a magnetic bead-based multiplex protein array system 
(EMD Millipore) according to the manufacturer’s protocol.
Novel Object Recognition test
After 5  months on the HFD, the novel object recognition task 
was performed to characterize the effect of obesity on learn-
ing and memory (11,26). The results of the test are influenced 
by both hippocampal and cortical impairment. The test consists 
of a habituation phase, acquisition (familiarization) phase, and 
trial phase. During the habituation phase, the animals explored 
the empty open-field arena for 5 minutes. Then, in the acquisi-
tion phase, the mice explore two identical objects for 2 minutes. 
After a 4-hour delay, a trial phase occurred. During this period, 
animals explored the familiar object and a novel object for 2 
minutes. Exploration of the objects was defined as directing the 
nose at a distance ≤2  cm to the object and/or touching it with 
the nose. For data collection and analysis, Ethovision software 
(Noldus Information Technology Inc., Leesburg, VA) was used. 
Sitting or climbing on it was not considered as an exploration. 
All objects used in this study were made of washable odorless 
plastic and were different in shapes and colors but identical in 
size. A percent of time spent exploring the novel object relative to 
the total time spent exploring both objects was used as a measure 
of novel object recognition. The Recognition Index (representing 
the time spent investigating the novel object [Tnovel] relative to the 
total object investigation) was used as the main index of reten-
tion, which was calculated according to the following formula: 
(Recognition Index  =  Tnovel/[Tnovel + Tfamiliar]). The arena and the 
objects were cleaned with 70% ethanol between the trials to pre-
vent the existence of olfactory cues.
Determination of Hippocampal Protein Carbonyl 
Content
As biomarkers of oxidative stress, protein carbonyl groups 
were quantified in cortical samples using the Protein Carbonyl 
Colorimetric Assay (Cayman Chemicals), following the manufac-
turer’s protocol.
Measurement of Neurovascular Coupling Responses
After behavioral testing, neurovascular coupling responses in the 
whisker barrel cortex elicited by contralateral whisker stimulation 
were assessed in anesthetized mice, as previously described (8,11,27–
30). In brief, mice in each group were anesthetized (α-chloralose 
(50 mg/kg, i.p.)/urethane (750 mg/kg, i.p.), endotracheally intubated 
and ventilated (MousVent G500; Kent Scientific Co, Torrington, 
CT). A  thermostatic heating pad (Kent Scientific Co, Torrington, 
CT) was used to maintain rectal temperature at 37°C. End-tidal CO2 
(including dead space) was controlled between 3.2% and 3.7% to 
keep blood gas values within the physiologic range. Arterial blood 
pressure was monitored throughout the experiment with a noninva-
sive blood pressure monitor (CODA Monitor; Kent Scientific Co). 
The blood pressure was within the physiologic range throughout the 
experiments (90–110 mm Hg). Mice were immobilized, placed on a 
stereotaxic frame (Leica Microsystems Inc, Buffalo Grove, IL), the 
scalp and periosteum were pulled aside. The animals were equipped 
with an open cranial window as described (29) and a glass-insulated 
tungsten microelectrode (impedance, 2–3 MΩ, Kation Scientific, 
LLC, Minneapolis, MN) was inserted stereotaxically into the left 
barrel cortex (3 mm lateral and 1.5 mm caudal to bregma; depth 
of 0.6  mm) through the ACSF-perfused open cranial window for 
recording local field potentials. An Ag/AgCl electrode inserted in 
the neck muscles served as reference electrode. Changes in cere-
bral blood flow (CBF) were assessed above the left barrel cortex 
using a laser Doppler probe (Transonic Systems Inc., Ithaca, NY) 
as described (29). The right whisker pad was stimulated by a bipo-
lar stimulating electrode placed to the ramus infraorbitalis of the 
trigeminal nerve and into the masticatory muscles. The stimulation 
protocol used to investigate NVC and somatosensory evoked field 
potentials consisted of 3 stimulation trials with an intertrial interval 
of 60 seconds, each delivering a 30-second train of electrical pulses 
(5 Hz, 1 mA, intensity, and 0.3 ms pulse width) to the mystacial pad. 
Changes in CBF were averaged and expressed as percent (%) increase 
from the baseline value. The electrical signal was amplified with a 
AC/DC differential amplifier (high pass at 1Hz, low pass at 1kHz) 
(Model 3000, A-M Systems, Inc. Carlsborg, WA), and digitalized by 
the PowerLab/Labchart data acquisition system (AD Instruments, 
Colorado Springs, CO) with the sampling rate of 40 kHz. The nega-
tive amplitude in the somatosensory evoked field potential response 
was considered as the field excitatory postsynaptic potential (fEPSP) 
(31). Experiments lasted ~30–40 minutes/mouse, which permitted 
stable physiological parameters to be obtained. The experimenter 
was blinded to the treatment of the animals.
Quantitative Real-Time RT-PCR
A quantitative real time RT-PCR technique was used to analyze 
mRNA expression of Nrf2 target genes (Cat, Sod3, Hmox1, Mgst2, 
Gclc), genes relevant for neurovascular dysfunction (including 
endothelial nitric oxide synthase [eNOS/Nos3], arginase [Arg1], 
gp91phox catalytic subunit of NADPH oxidase [Cybb], cyclooxy-
genase [Ptgs1], EET producing epoxygenases, and EET degrading 
soluble epoxide hydrolase [Ephx2]), senescence markers (p16Ink4A/
cyclin-dependent kinase inhibitor 2A/ Cdkn2a) and genes known to 
be involved in β-amyloid generation and Alzheimer’s disease using 
validated TaqMan probes (Applied Biosystems) and a Strategen 
MX3000 platform, as previously reported (7,8,26). In brief, total 
RNA was isolated from cortical and hippocampal samples from each 
experimental group with a Mini RNA Isolation Kit (Zymo Research, 
Orange, CA) and was reverse transcribed using Superscript III RT 
(Invitrogen) (32,33). Quantification was performed using the effi-
ciency-corrected ΔΔCq method. The relative quantities of the ref-
erence genes Hprt1, Gapdh, Actb and 18S were determined and a 
normalization factor was calculated based on the geometric mean 
for internal normalization. Fidelity of the PCR reaction was deter-
mined by melting temperature analysis and visualization of the prod-
uct on a 2% agarose gel.
Quantitative Mass Spectrometry Analysis
Selective reaction monitoring mass spectrometry was used to quan-
tify Nrf2-dependent antioxidant protein expression in cortical sam-
ples as previously described (34). For these assays, 60-μg amounts 
of tissue lysates were mixed with 8 pmol of bovine serum albumin 
(BSA) as an internal standard and 50 μL of 10% SDS. The samples 
were heated at 80°C for 15 minutes before precipitating the pro-
teins in 80% acetone overnight at −20°C. The protein pellet was 
dissolved in 60 μL of sample buffer and a 20-μL aliquot containing 
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20 μg of protein run 1.5 cm into a 12.5% SDS-polyacrylamide gel. 
The gel was fixed and stained with GelCode Blue (Pierce). For each 
sample, the entire 1.5-cm lane was cut out of the gel and divided 
coarsely. The gel pieces were washed to remove the stain, reduced 
with DTT, alkylated with iodoacetamide, and digested with 1 μg 
of trypsin overnight at room temperature. The peptides produced 
in the digest were extracted with 50% methanol, 10% formic 
acid in water. The extract was evaporated to dryness and reconstituted 
in 150 μL of 1% acetic acid in water for analysis. The samples were 
analyzed using selective reaction monitoring with a triple quadrupole 
mass spectrometer (ThermoScientific TSQ Vantage) configured with 
a splitless capillary column HPLC system (Eksigent, Dublin, CA).   
Samples (10 μL) were injected onto a 10 cm  ×  75 μm C18 capil-
lary column (Phenomenex, Jupiter C18). The column was eluted at 
160 nL/min with a 30-minute linear gradient of acetonitrile in 0.1% 
formic acid. Data were processed by using Pinpoint to find and inte-
grate the correct peptide chromatographic peaks. The response for 
each protein was taken as the total response for all peptides moni-
tored. To quantify protein expression, the relative abundance of each 
protein was first normalized to the BSA internal standard and then 
normalized to the geometric mean of cellular reference proteins (34).
Western Blotting
To assess BBB integrity immunoblotting studies for extravasated 
IgG in hippocampal homogenates were performed. In brief, hip-
pocampal samples (n  =  4–6 per experimental group) from mice 
transcardially perfused with ice-cold PBS were homogenized in ice-
cold phosphate buffered saline (PBS) with 1:100 Protease Inhibitor 
Cocktail (Sigma Aldrich). Samples were then subjected to SDS-PAGE 
gel electrophoresis and transferred to a nitrocellulose membrane. 
Membranes were blocked with 5% BSA (in 2% Tween in PBS, for 
2 hours, at room temperature) and incubated with a primary anti-
body directed against IgG (sheep anti-mouse IgG, peroxidase-linked 
whole antibody, 1:500, at room temperature, Amersham NXA931) 
and then incubated with a appropriate HRP-conjugated second-
ary antibody (for 2 hours, at room temperature). Membranes were 
developed using Amersham ECL Prime Western Blotting Detection 
Reagent (GE Healthcare). The relative abundance of studied pro-
teins was determined with densitometry. β-actin (mouse monoclonal, 
1:15,000, for 45 minutes, at room temperature, Abcam) was used for 
normalization purposes.
Immunofluorescent Labeling and Confocal 
Microscopy
Mice were transcardially perfused with 1× heparin containing PBS, 
then brains were removed and hemisected. The left hemispheres were 
fixed overnight in 4% paraformaldehyde, then were cryoprotected in 
a series of graded sucrose solutions (10%, 20%, and 30% overnight) 
and frozen in Cryo-Gel (Electron Microscopy Sciences, Hatfield, PA). 
Coronal sections of 35 µm were cut through the hippocampus and 
stored free-floating in cryopreservative solution (25% glycerol, 25% 
ethylene glycol, 25% 0.2M phosphate buffer, 25% distilled water) 
at −20°C. Selected sections were ~1.6 mm caudal to Bregma, repre-
senting the more rostral hippocampus. After washing (3 × 5 minutes 
with TBS then 3  ×  5 minutes with 1× TBS+0.25% TritonX-100), 
sections were treated with 1% of sodium-borohydride solution for 
5 minutes. After a second washing step (3 × 5 minutes with distilled 
water plus 3 × 5 minutes with 1× TBS) and blocking in 5% BSA/
TBS (with 0.5% Triton X-100, 0.3 M glycin and 1% fish gelatin; 
for 3 hours), sections were immunostained using primary antibodies 
overnifght at 4°C. The following primary antibodies were used: goat 
anti-mouse IgG (1:100, FITC conjugated; Cat N: 005-090-003, 
Jackson Immuno Research, West Grove, PA) to label extravasated 
IgG, rabbit anti-mouse Iba1 (1:50, unconjugated; Cat N: 019-19741, 
Wako, Richmond, VA) to label microglia and rabbit anti-mouse 
CD68 (1:100, unconjugated; Cat N: ab125212, Abcam, Cambridge, 
MA) to label activated microglia. The following secondary antibod-
ies were used: Alexa Fluor 647- and Alexa Fluor 568-labeled goat 
anti-rabbit IgG, (1:1,000, Cat N: 4414, Cell Signaling, Danvers, 
MA) and goat anti-rat IgG, (1:1,000, Cat N: A11077, Molecular 
Probes, Grand Island, NY). Sections were washed for 3 × 5 minutes 
with TBS then 3 × 5 minutes with 1× TBS+0.25% TritonX-100. For 
nuclear counterstaining, Hoechst 33342 (Life Technologies, Grand 
Island, NY) was used. Then the sections were transferred to slides 
and cover-slipped. Confocal images were captured using a Leica SP2 
MP confocal laser scanning microscope. Immunofluorescent labe-
ling for Iba1 and CD68 was used to identify microglia and activated 
microglia, respectively. The relative numbers of Iba1-positive micro-
glia and CD68-positive activated microglia per region of interest in 
the hippocampus were calculated. In each animal, four randomly 
selected fields from the hippocampus were analyzed in 6 nonadja-
cent sections. Six animals per group were analyzed.
Electrophysiological Studies for Synaptic Function 
and LTP
To assess how Nrf2 deficiency and obesity affect synaptic function, 
extracellular recordings were performed from acute hippocampal 
slices with an adapted protocol (11,35,36). Briefly, horizontal hip-
pocampal slices of 325 µm thickness from mice in each cohort were 
prepared in ice cold solution containing (in mmol/L) sucrose 110, 
NaCl 60, KCl 3, NaH2PO4 1.25, NaHCO3 28, sodium ascorbate 
acid 0.6, glucose 5, MgCl2 7, CaCl2 0.5 using a HM650V vibrat-
ing microtome (Thermo Scientific). Slices were then transferred to 
a holding chamber (Scientific Designs, Inc.) which contained oxy-
genated artificial cerebrospinal fluid (aCSF) of the following com-
position (in mmol/L) NaCl 126, KCl 2.5, NaH2PO4 1.25, MgCl2 2, 
CaCl2 2, NaHCO3 26, glucose 10, pyruvic acid 2, ascorbic acid 0.4. 
Slices were left to recover for at least 60 min at room temperature 
prior to recording in a brain slice chamber (Automate Scientific Inc., 
CA). Slices from the treatment and control groups were positioned 
on P5002A multi-electrode arrays (Alpha MED Scientific Inc, 
Japan) and perfused with aCSF at a rate of 2 ml/min, equilibrated 
with 95% O2 and 5% CO2 at 32°C. fEPSPs were invoked through 
stimulation of the Schaffer collaterals (0.2 msec biphasic pulse) and 
obtained from the CA1 region of the hippocampus. Threshold for 
evoking fEPSPs was determined and the stimulus was increased 
incrementally (5–100  µA) until the maximum amplitude of the 
fEPSP was reached. All other stimulation paradigms were induced 
at the same half-maximal stimulus strength, defined as 50% of the 
stimulus used to produce the maximum fEPSP amplitude, as deter-
mined for each individual slice. After a stable baseline recording of 
15 minutes was established, LTP was induced using high-frequency 
stimulation, which consisted of 100 pulses at 100 Hz applied with 
half-minute intervals. fEPSPs were monitored every 30 seconds 
for 60 minutes following high-frequency stimulation and were 
recorded with MED-64 system and Mobius software (Alpha MED 
Scientific Inc). Potentiation was calculated as the percent increase of 
the mean fEPSP descending slope following high-frequency stimula-
tion and normalized to the mean fEPSP descending slope of baseline 
recordings.
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Data Analysis
Gene expression data were normalized to the respective control 
mean values and are expressed as fold changes. Data were analyzed 
by one-way analysis of variance (ANOVA) followed by Tukey’s post-
hoc test. A p value less than .05 was considered statistically signifi-
cant. Data are expressed as mean ± SEM.
Results
Effect of a High-Fat Diet on Serum Biomarkers
We compared male Nrf2+/+ and Nrf2-/- mice after 5 months of the 
HFD. Blood glucose levels and serum triglyceride, cholesterol, and 
inflammatory cytokines levels are shown in Table 1.
Expression of Antioxidant Enzymes in Nrf2-/- Mice
Nrf2 deficiency was associated with decreased cerebral mRNA and/
or protein expression of Nrf2/ARE (antioxidant response element)-
driven antioxidant enzymes (Figure 1A and B), whereas expression of 
antioxidant enzymes, whose promoter does not contain an ARE motif 
was unaffected (Figure 1C). HFD did not result in significant changes 
in antioxidant gene expression in either group (Figure 1A–C).
Increased Oxidative Stress and Senescence in HFD-fed 
Nrf2-/- Mice
Although HFD tended to increase protein carbonyl content in the 
brains of Nrf2+/+ mice (Figure 1D), this difference did not reach stat-
istical significance. HFD-induced oxidative stress was more severe 
in Nrf2-/- mice, as shown by the significantly greater level of protein 
carbonyl content in the brains of HFD-fed Nrf2-/- mice as compared 
to that in HFD-fed Nrf2+/+ mice (Figure 1D). HFD-induced oxida-
tive stress was shown to promote cellular senescence in multiple tis-
sues (37,38). We found that exacerbation of HFD-induced oxidative 
stress in Nrf2-/- mice was associated with upregulation of the senes-
cence marker p16INK4A (Cdk2na; Figure 1E) in the brain.
Nrf2 Deficiency Exacerbates Obesity-Induced 
Neurovascular Uncoupling
In Nrf2+/+ mice feeding, a HFD resulted in significantly decreased 
whisker stimulation induced CBF responses in the contralateral whis-
ker barrel cortex, confirming our previous findings (8) (representative 
laser Doppler CBF tracings are shown in Figure 2A, summary data 
are shown in Figure 2B). Neurovascular coupling responses were also 
decreased in SD-fed Nrf2-/- mice (Figure 2). We found that Nrf2 defi-
ciency exacerbated the deleterious effects of obesity, quasi-abolishing 
neurovascular coupling responses (Figure 2A and B). Nrf2 deficiency 
and/or HFD feeding could reduce functional hyperemia by impairing 
neural activity evoked by whisker pad stimulation. To examine this 
possibility, we assessed the effects of Nrf2 deficiency and/or HFD feed-
ing by recording evoked neural activity. We found that the amplitude 
of the somatosensory field potentials produced by activation of the 
whisker pad do not differ between control and Nrf2-deficient mice 
and are also unaffected by HFD feeding (data not shown). Therefore, 
interaction of Nrf2 deficiency and obesity is unlikely to contribute 
to impaired functional hyperemia by modulating the neural activ-
ity evoked by whisker stimulation. Changes in mRNA expression of 
genes relevant for neurovascular dysfunction are shown in Figure 2C.
Nrf2 Deficiency Exacerbates Obesity-Induced BBB 
Disruption
Using extravasated plasma-derived IgG as a marker for increased 
hippocampal cerebromicrovascular permeability, we tested the 
hypothesis that increased obesity-induced oxidative stress in Nrf2 
deficiency is associated with an exacerbated BBB disruption. Western 
blot studies in hippocampal lysates demonstrated very low levels of 
IgG both in SD-fed and HFD-fed Nrf2+/+ mice (Figure 3A and B). 
Table 1. Effects of HFD on body mass and various serum biomarkers and metabolic parameters in Wt and Nrf2-/- mice
Wt (SD) Wt (HFD) Nrf2-/- (SD) Nrf2-/- (HFD)
Glucose (mmol/L, fasted) 4.8 ± 0.4 5.0 ± 0.4 2.5 ± 0.1* 2.7 ± 0.2*,**
Glucose (mmol/L, fed) 6.9 ± 0.4 9.4 ± 0.9 5.4 ± 0.5 7.0 ± 0.6
Total cholesterol (mmol/L) 2.4 ± 0.2 4.4 ± 0.6 2.0 ± 0.1 3.0 ± 0.2
Total triglycerides (mmol/L) 0.7 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 0.7 ± 0.1
IL-6 (pg/mL) 43 ± 8 149 ± 25* 40 ± 3 143 ± 67*,***
MCP-1 (pg/mL) 24 ± 2 22 ± 1 29 ± 3 52 ± 11*,**,***
KC (pg/mL) 117 ± 21 267 ± 44* 131 ± 25 658 ± 290*,***
G-CSF (pg/mL) 529 ± 110 1,973 ± 424* 527 ± 83 1,363 ± 306*,***
TNFα (pg/mL) 20 ± 2 23 ± 1 23 ± 2 37 ± 8*,**,***
IL-1β (pg/mL) 18 ± 2 19 ± 1 18 ± 1 34 ± 9*,**,***
IL-12 (pg/mL) 22 ± 2 25 ± 2 32 ± 8 43 ± 13
RANTES (pg/mL) 60 ± 10 58 ± 8 67 ± 15 72 ± 15
MIP-2 (pg/mL) 26 ± 2 30 ± 3 25 ± 2 30 ± 3
MIP-1α (pg/mL) 23 ± 2 26 ± 2 23 ± 1 32 ± 3*,***
MIP-1β (pg/mL) 28 ± 4 36 ± 4 37 ± 5 80 ± 22*,**,***
IL-10 (pg/mL) 38 ± 4 34 ± 3 47 ± 11 44 ± 3
IL-17 (pg/mL) 40 ± 7 105 ± 20* 64 ± 13 197 ± 71*,***
IP-10 (pg/mL) 1,179 ± 213 1,462 ± 271 1,062 ± 184 1,428 ± 240
IL-5 (pg/mL) 35 ± 8 25 ± 2 36 ± 4 22 ± 3
GM-CSF (pg/mL) 25 ± 2 26 ± 3 30 ± 5 155 ± 93
Note: Data are mean ± SEM (n = 4–20 for each data point).
*p < .05 vs Nrf2+/+ (SD), **p < .05 vs. Nrf2+/+ (HFD), ***p < .05 vs Nrf2-/- (SD); one-way ANOVA; G-CSF = Granulocyte-colony stimulating factor; HFD = 
High-fat diet; KC = Keratinocyte-derived chemokine; MIP-2 = Macrophage inflammatory protein 2; RANTES = Regulated on activation, normal T cell expressed 
and secreted; Wt = Wild type.
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There was no significant IgG leakage in SD-fed Nrf2-/- mice, whereas 
IgG content in the hippocampus of HFD-fed Nrf2-/- mice was signifi-
cantly increased (Figure 3A and B).
Nrf2 Deficiency Exacerbates Obesity-Induced 
Neuroinflammation in the Hippocampus
Previous studies suggest that leakage of plasma-derived fac-
tors through the damaged BBB has the potential to induce 
neuroinflammation by activating microglia (7). We found that in 
the hippocampi of control mice the number of activated CD68+ 
microglia was low (Figure 3C–E). In the present cohort of Nrf2+/+ 
mice HFD feeding did not alter significantly the number of acti-
vated microglia in the hippocampi. Nrf2 deficiency per se was also 
not associated with significant changes in microglia activation. In 
contrast, in the hippocampi of Nrf2-/- mice, obesity-induced oxi-
dative stress and BBB disruption was associated with exacerbated 
neuroinflammation as indicated by the increased number of CD68+ 
activated microglia (Figure 3E). Nrf2 deficiency and obesity did not 
alter the total number of microglia in the hippocampus (Figure 3D). 
Sustained activation of microglia in the brain of obese Nrf2 defi-
cient mice was associated with an increased expression of several 
proinflammatory cytokines and chemokines and other microglia 
activation-related factors (Figure 3F) in the hippocampi.
Effects of Nrf2 Deficiency and Obesity on 
Hippocampal Expression of APP and Genes 
Involved in APP-Dependent Signaling, Aβ 
Processing and Tauopathy
As observed in Supplementary Table S2, neither obesity nor Nrf2 
deficiency alone affected cerebral expression of APP, whose prote-
olysis generates β-amyloid (Aβ), the main component of amyloid 
plaques. Importantly, HFD-fed Nrf2-/- mice exhibited significant 
increases in APP expression. The effects of Nrf2 deficiency and 
obesity on hippocampal expression of other genes involved in APP-
dependent signaling, Aβ processing and tauopathy are shown in 
Supplementary Table 1. Interestingly, although we did not observe 
upregulation of either amyloid processing secretases, HFD signifi-
cantly increased presenilin enhancer 2 levels, which is known to 
enhance gamma-secretase activity and promote formation of amyl-
oid plaques (39,40).
Effects of Nrf2 Deficiency and Obesity on Synaptic 
Plasticity
Increased oxidative stress and neuroinflammation has been linked 
to impairment of long-term potentiation, which is thought to pro-
mote impairment of memory and learning. In order to characterize 
the effects of Nrf2 deficiency and obesity on synaptic function, we 
measured EPSP in the CA1 of hippocampi in response to electrical 
stimulation of the Schaffer collaterals pathway (with 5  µA steps 
increased up to 100 µA). Original recordings showing field EPSPs 
in the CA1 in response to the stimulation of the Schaffer collaterals 
in each group are shown in Figure 4A. We found that each group of 
mice exhibited normal basal synaptic properties. In particular, the 
ratio of evoked responses to the presynaptic fiber volley was simi-
lar in the experimental groups, showing that obesity does not affect 
neuronal EPSP. Following a 100Hz tetanic stimulation, the slope of 
field EPSP in the CA1 increased significantly less in the SD-fed Nrf2-/- 
group as compared to the SD-fed Nrf2+/+ controls during the 60 min-
utes experimental period (Figure 4B). In the Nrf2+/+ group, obesity 
also tended to decrease LTP, however, these differences did not reach 
statistical significance. In the hippocampi of Nrf2-deficient mice, 
obesity-induced impairment of LTP was exacerbated (Figure 4B).
Nrf2 Deficiency Exacerbates Obesity-Induced 
Cognitive Impairment
We tested the performance of the mice in the novel object recognition 
test. We found no significant difference in the time that mice from each 
group spent exploring the two identical objects placed at the opposite 
Figure 1. Nrf2 deficiency exacerbates obesity-induced oxidative stress. Effects 
of Nrf2 deficiency and obesity on expression of known Nrf2 target genes at 
the mRNA (A; quantitative polymerase chain reaction data) and protein (B; 
quantitative proteomics/selective reaction monitoring [SRM]) level. (C) Effects 
of Nrf2 deficiency and obesity on protein expression of antioxidant enzymes, 
whose promoter is not under the control of the Nrf2/ARE system (quantitative 
proteomics/SRM). (D) Nrf2 deficiency exacerbates high-fat diet (HFD)-induced 
oxidative stress. Note the significant increases in protein carbonyl content (a 
marker of oxidative stress) in brain samples from HFD-fed Nrf2-/- mice, which 
associates with up-regulation of Cdkn2a (p16INK4A; panel E), a marker of 
increased stress-induced cellular senescence. Data are mean ± SEM (n = 5–6 
for each data point). *p < .05 vs Wt (SD), #p < .05 vs Wt (HFD), &p < .05 vs Nrf2-/- 
(SD) (one-way analysis of variance, Tukey’s post hoc test).
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ends of the arena during the acquisition phase, confirming that the 
location of the objects did not affect the exploration behavior of mice 
(11,26). In the trial phase with two different objects (one novel, the 
other familiar), control mice explored the novel object for a signifi-
cantly longer time period, indicating their memory for the familiar 
object (Figure 4D). Among the four groups obese Nrf2-/- mice exhibited 
the lowest Recognition Index, which was statistically different from the 
control values. This result is consistent with their impaired hippocam-
pal- and cortical-dependent recognition memory (Figure 4D).
Discussion
This is the first study to demonstrate exacerbation of obesity-
induced oxidative stress, neurovascular uncoupling, BBB disruption, 
and neuroinflammation in a mouse model of genetic Nrf2 deficiency 
that recapitulates critical aspects of the cerebromicrovascular aging 
phenotype.
Previous studies provide ample evidence that the Nrf2/ 
Antioxidant Response Element (ARE) pathway has a critical role 
in microvascular protection (15–21,41–43), especially under patho-
physiological conditions associated with increased production of 
ROS. High-fat diet-induced obesity in aged rodents exerts deleteri-
ous effects on neurovascular coupling responses, at least in part, 
due to an increased production of ROS in the microvascular endo-
thelium (8). Here, we demonstrate that Nrf2 deficiency exacer-
bates obesity-induced oxidative stress (Figure 1) and neurovascular 
impairment (Figure 2), mimicking the aging phenotype (8). We pre-
dict that significant impairment of a key homeostatic mechanism 
matching energy supply with the needs of active neuronal tissue 
likely has a profound negative effect on brain function in elderly 
obese patients. This prediction is supported by the observations 
that cognitive function is significantly impaired in obese Nrf2-/- mice 
and that pharmacological inhibition of neurovascular coupling 
responses in control mice is associated with a similar degree of cog-
nitive impairment (11). Aging in both rodents and primates is asso-
ciated with Nrf2 dysfunction in the vasculature (20,21). Recently, 
we demonstrated that treatment with a pharmacological activator 
of Nrf2 (3,5,4′-trihydroxy-trans-stilbene/resveratrol (17)) signifi-
cantly improves neurovascular coupling responses in aged mice by 
restoring cerebromicrovascular endothelial function (29), which 
associates with cognitive improvement (44). We have compelling 
data that resveratrol treatment also rescues endothelial function 
in both larger arteries and peripheral microvessels in aged high-fat 
diet-fed mice in a Nrf2-dependent manner (17,18,23). Resveratrol 
was also shown to exert significant vasoprotective effects in HFD-
fed primates as well (10,45). On the basis of the aforementioned 
studies, we predict that treatment with Nrf2 activators may rescue 
cerebromicrovascular function and thereby neurovascular coupling 
responses in obese subjects as well.
The results of this study show that high-fat diet-induced obes-
ity in Nrf2 deficient mice promotes significant BBB disruption 
(Figure 3). The mechanisms of obesity-related BBB disruption are 
likely multifaceted and may involve increased endothelial oxidative 
stress (7), which is known to be exacerbated by Nrf2 deficiency 
(17,18). Obesity is known to promote low-grade systemic inflam-
mation, at least in part, by upregulating production of inflamma-
tory cytokines by the adipose tissue (9). Circulating inflammatory 
cytokines, derived from adipose tissue, readily reach the cerebral 
microcirculation impairing the barrier function of cerebromicrovas-
cular endothelial cells. Importantly, Nrf2 activity is known to limit 
cytokine-induced endothelial effects. Our current study provides 
evidence that through the damaged BBB in obese Nrf2-deficient 
Figure 2. Nrf2 deficiency exacerbates obesity-induced neurovascular uncoupling. (A) Representative traces of cerebral blood flow (CBF) measured with a laser 
Doppler probe above the whisker barrel cortex during contralateral whisker stimulation (30 seconds, 5 Hz) in wild type (Wt) and Nrf2-/- mice fed a high-fat diet 
(HFD) or standard diet (SD). Panel B depicts the summary data of the effect of HFD-induced obesity on CBF responses to whisker-stimulation in Wt and Nrf2-/- 
mice. (C) Quantitative polymerase chain reaction data showing HFD-induced changes in mRNA expression of genes relevant for the mediation of neurovascular 
coupling responses by NO, purinergic signaling and eicosanoid gliotransmitters in the cortices of Wt and Nrf2-/- mice. Data are mean ± SEM (n = 5–10 in each 
group). *p < .05 vs Wt (SD), #p < .05 vs Wt (HFD), &p < .05 vs Nrf2-/- (SD) (one-way analysis of variance, Tukey’s post hoc test).
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mice plasma constituents (e.g., IgG) enter the brain parenchyma 
(Figure 3), mimicking the aging phenotype (7). This observation is 
important as plasma-derived factors exert multifaceted effects on 
neuronal function, including the induction of neuroinflammation 
(13,46,47). There is strong evidence that plasma-derived IgG is a 
particularly potent stimulus for microglia activation in the brain 
Figure 3. Nrf2 deficiency exacerbates obesity-induced disruption of the blood-brain barrier and promotes neuroinflammation. (A,B) Obesity and Nrf2 deficiency-
induced changes in IgG content in the hippocampus of mice. Upper panel: original Western blot showing IgG heavy chain (A) and light chain (B) content in the 
hippocampi. β-actin was used as a loading control. Bar graphs are summary densitometric values. Data are mean ± SEM. *p < .05 vs Wt (SD), #p < .05 vs Wt 
(HFD); &p < .05 vs Nrf2-/- (SD). (C) Confocal images showing CD68-positive (red fluorescence, arrowheads) activated microglia in the hippocampi from wild-type 
SD-fed), wild-type HFD-fed, Nrf2-/- SD-fed, and Nrf2-/- HFD-fed animals. Green fluorescence: Iba-1 microglia marker. Bar graphs are summary data for relative 
changes in total Iba-1-positive microglia (D) and CD68+/Iba-1+-activated microglia (E). Data are mean ± SEM. *p < .05 vs Wt (SD), #p < .05 vs Wt (HFD); &p < .05 vs 
Nrf2-/- (SD). (F) Quantitative polymerase chain reaction data showing HFD-induced changes in mRNA expression of proinflammatory cytokines and chemokines 
and other microglia activation-related factors in the hippocampi of Wt and Nrf2-/- mice. Data are mean ± SEM. *p < .05.
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(7). Other plasma constituents that likely contribute to microglia 
activation upon BBB disruption include thrombin, fibrinogen, and 
circulating inflammatory cytokines. Here, we provide evidence that 
in obese Nrf2-deficient mice, similar to obese aged mice (7), BBB 
disruption and increased extravasation of plasma constituents are 
associated with an exacerbated neuroinflammatory response as 
shown by the increased number of activated microglia and upregu-
lation of inflammatory mediators (e.g., IL-1β (48)) in the hippocam-
pus. On the basis of the present and previous findings we propose 
that age-related microvascular Nrf2 dysfunction likely contributes 
to exacerbation of obesity-induced BBB disruption and neuroin-
flammation in aged mice (7).
Clinical studies demonstrate that increased inflammation pre-
dicts cognitive decline. Results of preclinical studies support this 
concept by showing that microglia-derived proinflammatory 
cytokines, chemokines, proteases (MMPs), and reactive oxygen 
species promote neuronal dysfunction, including impairment of 
synaptic function. To determine the functional consequences of exac-
erbated neuroinflammation in obese Nrf2-deficient mice, we studied 
LTP (an increase in synaptic strength), which plays an important 
role in the establishment and storage of stable long-term memories 
in the hippocampus. We found that HFD-induced obesity tended 
to decrease LTP in the hippocampus, confirming previous findings 
(49). In obese Nrf2-deficient mice, LTP was substantially reduced, 
which, together with neurovascular uncoupling, likely contributes to 
impaired cognitive performance (Figure 4A–C). Interestingly, Nrf2 
deficiency itself also appears to decrease LTP, supporting the concept 
that Nrf2 deficiency exerts multifaceted adverse neuronal effects. For 
example, recent studies show that Nrf2 ortholog SKN-1 regulates 
synaptic transmission in C. elegans (50). Further, in mice, intrahip-
pocampal injections of a lentiviral vector expressing Nrf2 improve 
spatial learning (51). The exact mechanisms linking Nrf2 activation 
to synaptic strength in mice are not understood and should be eluci-
dated in future studies.
Epidemiological studies provide evidence that in addition to the 
established association of obesity with vascular cognitive impair-
ment, there is a direct relationship between obesity and pathogenesis 
of AD (reviewed in ref. (52)). In particular, BBB disruption, increased 
inflammatory status and oxidative stress are thought to contribute 
to the pathogenesis of AD, via mechanisms that include dysregula-
tion of AD-related gene expression (7,26). To determine whether in 
Nrf2-deficient mice exacerbated obesity-induced cerebromicrovas-
cular alterations and neuroinflammation were sufficient to trigger 
early processes involved in the pathogenesis of Alzheimer’s disease, 
we assessed hippocampal expression of genes involved in regula-
tion of the cellular APP-dependent signaling pathways, beta-amy-
loid generation and processing and the pathogenesis of tauopathy. 
Importantly, obesity in Nrf2-deficient mice resulted in significant 
alterations in amyloidogenic gene expression, including upregula-
tion of cerebral expression of APP, whose proteolysis generates Aβ, 
the main component of amyloid plaques (Supplementary Table S1). 
This finding is consistent with the results of previous studies show-
ing that increased oxidative stress induces APP expression and that 
Nrf2 deficiency (53) and HFD-induced obesity (54) exacerbate AD 
pathologies in genetic mouse models.
Collectively, our findings provide evidence that Nrf2-driven free 
radical detoxification pathways have an important role in neuro-
vascular protection in obesity (Figure 4D). We find that Nrf2 dys-
function compromises cerebromicrovascular and brain health, by 
exacerbating obesity-induced neurovascular uncoupling, BBB dis-
ruption, neuroinflammation, and synaptic dysfunction, promoting 
cognitive impairment. We propose that pathological conditions that 
impair cellular Nrf2 activity, such as advanced aging (15,19–21,42), 
render the cerebral microvasculature vulnerable to the deleterious 
effects of obesity, which likely plays a critical role in the augmented 
pathogenesis of VCI and AD. Based on our present and previous 
Figure 4. (A) Original recordings showing the effects of Nrf2 deficiency and 
high-fat diet (HFD)-induced obesity on field excitatory postsynaptic potential 
(EPSP) in the CA1 in response to the stimulation of the Schaffer collaterals on 
hippocampal brain slices before (10 minutes) and 1 hour after (70 minutes) 
4  ×  100 Hz tetanus. (B) Long-term potentiation shown as change of field 
EPSP (fEPSP) slope following a 4  ×  100 Hz (1 second) tetanic stimulus in 
the CA1 of the hippocampus. Data are normalized to baseline responses and 
depicted as mean ± SEM (n = 8–12 for each data point); *p < .05 vs Wt (SD), 
#p < .05 vs Wt (HFD) during the last 5 minutes of the recording. (C) The novel 
object recognition task test used to evaluate recognition memory in mice. 
The Recognition Index (representing the time spent investigating the novel 
object relative to the total object investigation) was used as the main index 
of retention. Data are mean ± SEM. *p < .05 vs Wt (SD). (D) Proposed scheme 
depicting the likely role of age-related Nrf2 dysfunction in exacerbation 
of obesity-induced oxidative stress, BBB disruption, neuroinflammation, 
neurovascular dysfunction, and synaptic dysfunction, all of which contribute 
to cognitive impairment in obese elderly subjects.
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findings, there is a clear opportunity for pharmacological interven-
tion to facilitate induction of Nrf2-driven homeostatic pathways by 
pharmacological treatments for the prevention of cognitive impair-
ment in obese elderly patients.
Supplementary Material
Supplementary data is available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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